Iovance Biotherapeutics (IOVA) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Iovance Biotherapeutics (IOVA) over the last 14 years, with Q3 2025 value amounting to $300.8 million.
- Iovance Biotherapeutics' Cash & Current Investments rose 8322.76% to $300.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.8 million, marking a year-over-year increase of 8322.76%. This contributed to the annual value of $323.8 million for FY2024, which is 1569.1% up from last year.
- Iovance Biotherapeutics' Cash & Current Investments amounted to $300.8 million in Q3 2025, which was up 8322.76% from $301.2 million recorded in Q2 2025.
- Over the past 5 years, Iovance Biotherapeutics' Cash & Current Investments peaked at $626.3 million during Q1 2023, and registered a low of $164.2 million during Q3 2024.
- In the last 3 years, Iovance Biotherapeutics' Cash & Current Investments had a median value of $301.2 million in 2025 and averaged $323.0 million.
- In the last 5 years, Iovance Biotherapeutics' Cash & Current Investments plummeted by 5457.2% in 2024 and then soared by 8322.76% in 2025.
- Iovance Biotherapeutics' Cash & Current Investments (Quarter) stood at $279.9 million in 2023, then rose by 15.69% to $323.8 million in 2024, then dropped by 7.09% to $300.8 million in 2025.
- Its last three reported values are $300.8 million in Q3 2025, $301.2 million for Q2 2025, and $359.7 million during Q1 2025.